As per the new research report by RNCOS, “US Non-Invasive Prenatal Diagnostics - Market Insight”, Sequenom continues to lead the US NIPD market. The company enjoys the first entrant advantage. Its NIPD test MaterniT21 is far more, the most popular test in the market, having delivered results to almost 100,000 users since its introduction in the market. The firm has a sound business strategy, in accordance to which it has successfully increased insurance coverage of its test and has gained popularity amongst the healthcare providers. Our research reveals that despite doing well, the company need to be aware of the competition, which is all geared to catch-up. In the rapidly evolving market, players are forming tie-ups and alliances, which present new and unique challenges.
Currently, the NIPD market is represented by only a few companies such as Sequenom, Verinata, Ariosa diagnostics and Natera, being the latest entrant. The sector has a highly untapped potential and is expected that it will evolve greatly in the future. Research and innovation in the sector is very robust and there are several clinical trials being undergone at present. Regulatory intervention is weak as NIPD tests are classified as Lab Developed Tests (LDTs) that do not require FDA regulation. Backed by such factors, the US NIPD market is expected to grow at a high CARG of around 49% during 2012-2017.
The report provides an in-depth research and rational analysis of the current status and expected position of the US NIPD Market by 2017. Moreover, opportunity assessment for companies in the US NIPD Market in terms of leading technologies is also analyzed in the report. In addition, the report elaborates on the various restraints faced by the sector. To provide a holistic view, it also provides a competitive assessment of the major players describing their key business and comparing their strengths and weaknesses.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM450.htm
Some of our Related Reports are:
- Global Insulin Delivery Devices Market Forecast to 2017 (http://www.rncos.com/Report/IM494.htm)
- Genetic Testing Market Outlook to 2017 (http://www.rncos.com/Report/IM492.htm)
- Analysis of Coronary Stent in US (http://www.rncos.com/Report/IM489.htm)
- US Healthcare IT Market Outlook to 2017 (http://www.rncos.com/Report/IM487.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.